Security key
87583X109
Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX)
CUSIP: 87583X109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 143,181,938
- Total 13F shares
- 98,595,824
- Share change
- +232,084
- Total reported value
- $845,901,469
- Put/Call ratio
- 38%
- Price per share
- $8.58
- Number of holders
- 116
- Value change
- +$2,628,498
- Number of buys
- 55
- Number of sells
- 58
Report period
Q2 2024
Institutions
116
Top holders
10
TNGX full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Tango Therapeutics, Inc. SEC filings
Tango Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87583X109
Recent filing periods:
Top shareholders of TNGX - Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TRV GP IV, LLC |
13F
|
Company |
13%
|
19,201,475
|
$152,459,712 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
9.3%
|
13,330,736
|
$105,846,044 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
6.6%
|
9,491,655
|
$75,363,741 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
3/4/5
13F
|
Other* · Company |
5.7%
from 13F
|
17,527,671
mixed-class rows
|
$139,494,711 | — | 13 Oct 2023 | |
| Nextech Invest Ltd. |
13F
|
Company |
3.9%
|
5,533,980
|
$43,939,801 | — | 31 Mar 2024 | |
| Southpoint Capital Advisors LP |
13F
|
Company |
3.7%
|
5,276,699
|
$41,896,990 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
3%
|
4,321,551
|
$34,314,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
3,861,362
|
$30,659,215 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
3,080,885
|
$24,462,228 | — | 31 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
2%
|
2,892,663
|
$22,967,744 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
2,866,098
|
$22,756,818 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.6%
|
2,294,206
|
$18,215,996 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
1.5%
|
2,194,841
|
$17,427,038 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.1%
|
1,540,000
|
$12,227,600 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.94%
|
1,350,145
|
$10,720,151 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.83%
|
1,188,349
|
$9,435,491 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
1,133,535
|
$9,001,444 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.52%
|
750,000
|
$5,955,000 | — | 31 Mar 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.49%
|
708,385
|
$5,624,577 | — | 31 Mar 2024 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.49%
|
708,384
|
$5,625,000 | — | 31 Mar 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.44%
|
630,000
|
$5,002,200 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
613,702
|
$4,872,794 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.35%
|
506,382
|
$4,020,673 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.33%
|
466,118
|
$3,700,977 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.28%
|
401,129
|
$3,184,965 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.27%
|
379,477
|
$3,013,047 | — | 31 Mar 2024 | |
| Mass General Brigham, Inc |
13F
|
Company |
0.25%
|
354,192
|
$2,812,284 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.24%
|
348,336
|
$2,765,788 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
307,235
|
$2,439,446 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.16%
|
235,656
|
$1,871,108 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.15%
|
220,019
|
$1,746,951 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.14%
|
196,384
|
$1,559,289 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
191,433
|
$1,519,978 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
183,486
|
$1,456,879 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
179,519
|
$1,425,381 | — | 31 Mar 2024 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.12%
|
168,400
|
$1,337,096 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
158,226
|
$1,256,314 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.1%
|
150,274
|
$1,193,176 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.1%
|
140,995
|
$1,119,500 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
126,250
|
$1,002,425 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
122,697
|
$974,214 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.08%
|
109,269
|
$867,596 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
108,043
|
$857,862 | — | 31 Mar 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.07%
|
100,691
|
$799,486 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
86,161
|
$684,118 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.06%
|
81,132
|
$644,188 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.06%
|
80,200
|
$636,788 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.05%
|
78,477
|
$623,107 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
71,437
|
$567,199 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.05%
|
67,115
|
$532,893 | — | 31 Mar 2024 |
Institutional Holders of Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) as of Q2 2024
As of 30 Jun 2024,
Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,595,824 shares.
The largest 10 holders included
TRV GP IV, LLC, EcoR1 Capital, LLC, FMR LLC, Boxer Capital, LLC, Nextech Invest Ltd., Southpoint Capital Advisors LP, T. Rowe Price Investment Management, Inc., BlackRock Inc., VANGUARD GROUP INC, and Bain Capital Life Sciences Investors, LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
124
Q2 2024 holders
116
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.